INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Novartis
Johnson & Johnson Enterprise Innovation Inc.
Janssen Pharmaceutica N.V., Belgium
Johnson & Johnson Enterprise Innovation Inc.
Johnson & Johnson Enterprise Innovation Inc.
Debiopharm International SA
Monteris Medical
Merck Sharp & Dohme LLC
Genmab
Akamis Bio
Hoffmann-La Roche
Merck Sharp & Dohme LLC
CytoDyn, Inc.
Hoffmann-La Roche
AstraZeneca
NeuGATE Theranostics
Graegis Pharmaceuticals Ltd
Coordination Pharmaceuticals, Inc.
Tactical Therapeutics, Inc.
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
BioMimetix JV, LLC
DEKA Biosciences
BeiGene
EMD Serono
Eurofarma Laboratorios S.A.
Eurofarma Laboratorios S.A.